Geralyn S. Ritter - Mar 31, 2023 Form 4 Insider Report for Organon & Co. (OGN)

Role
Head of Ext. Affairs and ESG
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Geralyn S. Ritter
Stock symbol
OGN
Transactions as of
Mar 31, 2023
Transactions value $
-$15,101
Form type
4
Date filed
4/4/2023, 08:19 PM
Previous filing
Mar 2, 2023
Next filing
May 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise +1.91K +25.15% 9.49K Mar 31, 2023 Direct F1
transaction OGN Common Stock Tax liability -$15.1K -654 -6.89% $23.09 8.84K Mar 31, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -1.91K -33.33% $0.00 3.82K Mar 31, 2023 Common Stock 1.91K Direct F2, F3
transaction OGN Stock Option (right to buy) Award $0 +42K $0.00 42K Mar 31, 2023 Common Stock 42K $23.52 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit converts into one share of Organon & Co. common stock.
F2 Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock.
F3 On March 31, 2023, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2024 and March 31, 2025.
F4 The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026.